An analysis of patient data from across Michigan found scores from the Decipher Biopsy test independently aligned with outcomes.

Some prostate tumors transition from being glandular to more nerve-like in response to drugs that block the androgen receptor; a new preclinical study examines the underlyin

Using next-generation sequencing, the UPSeq test assesses 15 biomarkers to find aggressive prostate cancer that can be missed by biopsies or imaging tests.

The new approach blocks the interaction between cancer cells and immune receptors, showing promise in mice.

Urine test found to be extremely accurate at detecting aggressive prostate cancer with few false negatives.

Clinical trials underway are testing whether drugs that target the androgen receptor – successful in controlling prostate cancer – could also work against the coronavirus.